NO971686D0 - HER4-humanreseptortyrosinkinase - Google Patents
HER4-humanreseptortyrosinkinaseInfo
- Publication number
- NO971686D0 NO971686D0 NO971686A NO971686A NO971686D0 NO 971686 D0 NO971686 D0 NO 971686D0 NO 971686 A NO971686 A NO 971686A NO 971686 A NO971686 A NO 971686A NO 971686 D0 NO971686 D0 NO 971686D0
- Authority
- NO
- Norway
- Prior art keywords
- humanreseptortyrosinkinase
- her4
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/71—Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
- A61K47/6425—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent the peptide or protein in the drug conjugate being a receptor, e.g. CD4, a cell surface antigen, i.e. not a peptide ligand targeting the antigen, or a cell surface determinant, i.e. a part of the surface of a cell
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
- A61K47/6835—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site
- A61K47/6849—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody targeting a receptor, a cell surface antigen or a cell surface determinant
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/4756—Neuregulins, i.e. p185erbB2 ligands, glial growth factor, heregulin, ARIA, neu differentiation factor
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/485—Epidermal growth factor [EGF] (urogastrone)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2863—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for growth factors, growth regulators
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/475—Assays involving growth factors
- G01N2333/4756—Neuregulins, i.e. p185erbB2 ligands, glial growth factor, heregulin, ARIA, neu differentiation factor
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US32344294A | 1994-10-14 | 1994-10-14 | |
PCT/US1995/013524 WO1996012019A2 (en) | 1994-10-14 | 1995-10-10 | Her4 human receptor tyrosine kinase or the epidermal growth factor receptor family |
Publications (2)
Publication Number | Publication Date |
---|---|
NO971686D0 true NO971686D0 (en) | 1997-04-11 |
NO971686L NO971686L (en) | 1997-06-16 |
Family
ID=23259216
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO971686A NO971686L (en) | 1994-10-14 | 1997-04-11 | HER4-humanreseptortyrosinkinase |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP0787187A1 (en) |
JP (1) | JPH10507362A (en) |
AU (1) | AU3963295A (en) |
CA (1) | CA2202533A1 (en) |
FI (1) | FI971532A (en) |
IL (1) | IL115642A0 (en) |
MX (1) | MX9702664A (en) |
NO (1) | NO971686L (en) |
WO (1) | WO1996012019A2 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU9805398A (en) * | 1997-10-15 | 1999-05-03 | Children's Medical Center Corporation | Novel human egf receptors and use thereof |
WO1999023209A2 (en) * | 1997-10-31 | 1999-05-14 | Georgetown University Medical Center | ErbB-4 TARGETED RIBOZYMES |
CA2515081A1 (en) | 2003-02-07 | 2004-08-19 | Protein Design Labs, Inc. | Amphiregulin antibodies and their use to treat cancer and psoriasis |
US8652787B2 (en) | 2008-11-12 | 2014-02-18 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Use of ERBB4 as a prognostic and therapeutic marker for melanoma |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2103323A1 (en) * | 1992-11-24 | 1994-05-25 | Gregory D. Plowman | Her4 human receptor tyrosine kinase |
-
1995
- 1995-10-10 CA CA002202533A patent/CA2202533A1/en not_active Abandoned
- 1995-10-10 AU AU39632/95A patent/AU3963295A/en not_active Abandoned
- 1995-10-10 MX MX9702664A patent/MX9702664A/en unknown
- 1995-10-10 WO PCT/US1995/013524 patent/WO1996012019A2/en not_active Application Discontinuation
- 1995-10-10 EP EP95937555A patent/EP0787187A1/en not_active Withdrawn
- 1995-10-10 JP JP8513469A patent/JPH10507362A/en active Pending
- 1995-10-15 IL IL11564295A patent/IL115642A0/en unknown
-
1997
- 1997-04-11 FI FI971532A patent/FI971532A/en not_active IP Right Cessation
- 1997-04-11 NO NO971686A patent/NO971686L/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
AU3963295A (en) | 1996-05-06 |
JPH10507362A (en) | 1998-07-21 |
NO971686L (en) | 1997-06-16 |
WO1996012019A2 (en) | 1996-04-25 |
FI971532A0 (en) | 1997-04-11 |
WO1996012019A3 (en) | 1996-08-15 |
FI971532A (en) | 1997-06-11 |
CA2202533A1 (en) | 1996-04-25 |
MX9702664A (en) | 1997-06-28 |
EP0787187A1 (en) | 1997-08-06 |
IL115642A0 (en) | 1996-01-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE59508357D1 (en) | STEREOMICROSCOP | |
DE59501347D1 (en) | Hydroxyphenylureas | |
DE59506964D1 (en) | POLYGLYCERINPOLYRICINOLEATE | |
ATA108995A (en) | DIFFERENZDRUCKAKKUMULATOR | |
DE59508868D1 (en) | Dihydrofarnesal | |
DE69523962D1 (en) | Winkelgeschwindigkeitsmessaufnehmer | |
DE59510691D1 (en) | Dipolspeiseanordnung | |
DE59503633D1 (en) | CYCLONIFIER | |
NO971686L (en) | HER4-humanreseptortyrosinkinase | |
ATA11894A (en) | STAUFÖRDERBAHN | |
BR9506519A (en) | Azatrioxaspiroalkenes | |
DE59507451D1 (en) | Cyanoisoxazoles | |
DE29501964U1 (en) | dragon-fly | |
FI1523U1 (en) | Faestdon Foer skaermvaeggar | |
BR9403309A (en) | Choppometer | |
BR7400242U (en) | Tele-command | |
BR9405358A (en) | Moto-electro-continuous | |
BR9405342A (en) | Auto-lift | |
BR9404091A (en) | Muchileiro | |
BR9403990A (en) | Quandriciclo cycle-car | |
BR9403759A (en) | Mastercalc | |
BR9403758A (en) | Multiplic | |
BR9403310A (en) | Regulex | |
BR9400287A (en) | Bi-toilet | |
BR9403098A (en) | Turnmeter |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |